Asthma inhalers adopted more slowly for minority patients and children

December 23, 2005

Inhaled steroid medications for asthma, which have greatly reduced the need for patients to be hospitalized with serious symptoms, were significantly less likely to be prescribed for minority patients and children during the years soon after their introduction. In the January 2006 issue of the journal Medical Care, investigators from the Massachusetts General Hospital Institute for Health Policy report one of the first studies to examine how disparitites in health care change over time, reflecting how the introduction of a new technology differs among racial, ethnic or other groups.

"Previous studies of health care disparities have tended to look at one point in time, but a longer-term picture allows us to see whether disparities are a static or dynamic problem," says Timothy Ferris, MD, of the MGH Institute for Health Policy, the article's lead author. "Our results support the theory that disparities might be greater in the early stages after a technology is introduced and that attempts to reduce disparities might focus on this important period."

In order to track the adoption of inhaled steroid medications for asthma after their introduction in the 1980s, the researchers analyzed data from the National Ambulatory Medical Care Survey from 1989 to 1998. In this annual survey, conducted by the National Center for Health Statistics, physicians complete a form after outpatient visits during a randomly selected week, answering questions about patients' diagnoses and the treatments provided. The researchers identified 3,671 physician visits by patients with asthma during the years studied, determined whether or not inhaled steroids were prescribed or administered during those visits, and also analyzed information on patients' age and race or ethnicity.

During the first two years studied, minority patients were less than half as likely to receive inhaled steroid medications as were non-minority patients. While the overall difference in usage between minority and non-minority patients resolved by the mid-1990s, that change reflected increased usage only among African American patients; the low rate of prescription for Hispanic patients remained virtually unchanged. Children also were significantly less likely than adults to receive inhaled steroid medications throughout the years studied, although there was some increase in usage for the youngest children.

"Technology adoption in health care requires both the doctor to recommend a new agent and the patient to accept it. Many if not most of the steps in that process are not controlled by the patient," Ferris says. "Some factors behind these disparities might be the greater access non-minority patients usually have to specialists, who are more likely to use new technologies, and the higher cost of new medications, which makes them less accessible to the poor and underinsured. Children often do not get access to new technologies because drug manufacturers may not invest in the trials required to demonstrate safety and effectiveness in children. When you put these factors together, it appears that the minority children were the last to benefit from this effective medication."

The researchers also note that there is no way of knowing the correct usage rate for these medications among the various groups. For example, while usage differences between white and black patients seemed to disappear, black patients might still be undertreated, since asthma is more common and often more serious among African Americans. Further studies of factors underlying these and other disparities are being conducted by the Disparities Solutions Center in the MGH Institute for Health Policy.
Co-authors of the study are Karen Kuhlthau, PhD, and James Perrin, MD, of the MGH Center for Child and Adolescent Health Policy; John Ausiello, of the MGH Institute for Health Policy; and Robert Kahn, MD, MPH, Cincinnati Children's Medical Center.

Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of nearly $500 million and major research centers in AIDS, cardiovascular research, cancer, cutaneous biology, medical imaging, neurodegenerative disorders, transplantation biology and photomedicine. In 1994, MGH and Brigham and Women's Hospital joined to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups, and nonacute and home health services.

Massachusetts General Hospital

Related Asthma Articles from Brightsurf:

Breastfeeding and risks of allergies and asthma
In an Acta Paediatrica study, exclusive breastfeeding for the first 3 months was linked with a lower risk of respiratory allergies and asthma when children reached 6 years of age.

Researchers make asthma breakthrough
Researchers from Trinity College Dublin have made a breakthrough that may eventually lead to improved therapeutic options for people living with asthma.

Physics vs. asthma
A research team from the MIPT Center for Molecular Mechanisms of Aging and Age-Related Diseases has collaborated with colleagues from the U.S., Canada, France, and Germany to determine the spatial structure of the CysLT1 receptor.

New knowledge on the development of asthma
Researchers at Karolinska Institutet in Sweden have studied which genes are expressed in overactive immune cells in mice with asthma-like inflammation of the airways.

Eating fish may help prevent asthma
A scientist from James Cook University in Australia says an innovative study has revealed new evidence that eating fish can help prevent asthma.

Academic performance of urban children with asthma worse than peers without asthma
A new study published in Annals of Allergy, Asthma and Immunology shows urban children with poorly controlled asthma, particularly those who are ethnic minorities, also suffer academically.

Asthma Controller Step Down Yardstick -- treatment guidance for when asthma improves
The focus for asthma treatment is often stepping up treatment, but clinicians need to know how to step down therapy when symptoms improve.

Asthma management tools improve asthma control and reduce hospital visits
A set of comprehensive asthma management tools helps decrease asthma-related visits to the emergency department, urgent care or hospital and improves patients' asthma control.

Asthma linked to infertility but not among women taking regular asthma preventers
Women with asthma who only use short-acting asthma relievers take longer to become pregnant than other women, according to research published in the European Respiratory Journal.

What are the best ways to diagnose and manage asthma?
A team of experts from The University of Texas Medical Branch at Galveston examined the current information available from many different sources on diagnosing and managing mild to moderate asthma in adults and summarized them.

Read More: Asthma News and Asthma Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to